Ye Xin Tao, Buratto Edward, Konstantinov Igor E, d'Udekem Yves
Cardiac Surgery Unit, Royal Children's Hospital, Melbourne, VIC, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
Interact Cardiovasc Thorac Surg. 2019 Dec 1;29(6):960-966. doi: 10.1093/icvts/ivz204.
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether the transatrial-transpulmonary approach to tetralogy of Fallot repair in non-neonatal patients provides superior outcomes compared with the transventricular approach. Altogether, 175 papers were found using the reported search, of which 11 represented the best evidence to answer the clinical question. Two randomized controlled trials (RCTs) and 3 observational studies showed that the transatrial approach resulted in better preservation of right ventricular (RV) function, whereas 4 observational studies showed no significant difference. Three observational studies showed better attenuation of RV dilatation, whereas 3 showed no difference. One RCT and 2 observational studies showed lower incidence of postoperative ventricular arrhythmias, while 1 RCT and 4 observational studies showed no difference. Two observational studies demonstrated greater freedom from reoperation, 1 RCT and 2 observational studies showed no difference, while 1 retrospective study observed a higher incidence of residual RV outflow tract obstruction and lower freedom from reoperation in infants. Two observational studies reported lower risk of requiring pulmonary valve replacement, whereas 2 reported no difference. Three observational studies reported superior exercise capacity, while 1 reported no difference. No difference in long-term survival was demonstrated. The results presented suggest that transatrial repair of tetralogy of Fallot confers superior or equivalent outcomes in terms of preservation of RV function and volume, ventricular arrhythmias, need for pulmonary valve replacement, and exercise capacity compared with transventricular repair. However, the incidence of residual RV outflow tract obstruction may be higher in infants undergoing transatrial repair.
根据结构化方案撰写了一篇心脏外科领域的最佳证据主题文章。所探讨的问题是,在非新生儿患者中,经心房 - 经肺动脉途径修复法洛四联症与经心室途径相比,是否能带来更好的治疗效果。通过报告的检索方式,共找到175篇论文,其中11篇代表了回答该临床问题的最佳证据。两项随机对照试验(RCT)和三项观察性研究表明,经心房途径能更好地保留右心室(RV)功能,而四项观察性研究则显示无显著差异。三项观察性研究表明经心房途径能更好地减轻RV扩张,而三项研究显示无差异。一项RCT和两项观察性研究表明术后室性心律失常的发生率较低,而一项RCT和四项观察性研究则显示无差异。两项观察性研究表明再次手术的自由度更高,一项RCT和两项观察性研究显示无差异,而一项回顾性研究观察到婴儿中残余RV流出道梗阻的发生率较高且再次手术的自由度较低。两项观察性研究报告需要进行肺动脉瓣置换的风险较低,而两项报告无差异。三项观察性研究报告运动能力更佳,而一项报告无差异。未显示长期生存率存在差异。所呈现的结果表明,与经心室修复相比,法洛四联症的经心房修复在保留RV功能和容积、室性心律失常、肺动脉瓣置换需求以及运动能力方面具有更好或相当的治疗效果。然而,接受经心房修复的婴儿中残余RV流出道梗阻的发生率可能更高。